Neil Mahapatra's guest appearances

Neil Mahapatra

Danny In The Valley

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

The Oxford Biotech Podcast

Bill Gates

Benedict Evans

Ben Thompson

Patrick Collison

Marc Andreessen

Mike Alfred

Alex Mashinsky

Scott Kupor

Ben Horowitz

Naveen Jain

Jeff Bezos

Jordan Fisher

Scott Galloway

Robert Bollinger

Jon Callaghan

OwlTail

Gavin Sathianathan

Medical cannabis is expected to reach 56.7B market value by 2026. On this episode we hear from Oxford Cannabinoid Technologies co-founders Neil Mahapatra (Kingsley Capital Partners, Rothschild, Morgan Stanley) and Gavin Sathianathan (Alta Flora, Facebook, Bain) about their use of technological advances and a network innovation model to develop patient-saving pharmaceuticals from cannabis.  Music from: https://freesound.org/   OCT: https://www.oxcantech.com/

Medical cannabis is expected to reach 56.7B market value by 2026. On this episode we hear from Oxford Cannabinoid Technologies co-founders Neil Mahapatra (Kingsley Capital Partners, Rothschild, Morgan Stanley) and Gavin Sathianathan (Alta Flora, Facebook, Bain) about their use of technological advances and a network innovation model to develop patient-saving pharmaceuticals from cannabis.  Music from: <a href="https://freesound.org/" rel="nofollow" target="_blank">https://freesound.org/ </a>  OCT: <a href="https://www.oxcantech.com/" rel="nofollow" target="_blank">https://www.oxcantech.com/</a>

Medical Cannabis: Oncology and Pain Game Changer, or just a Pipe Dream? With OCT Founders Gavin Sathianathan and Neil Mahapatra.

The Sunday Times’ tech correspondent Danny Fortson brings on Neil Mahapatra, founder of Kingsley Capital and Oxford Cannabinoid Technologies, to talk about his early days in investment banking (3:30), getting a job with Lord Rothschild (5:50), setting up his own investment firm (7:30), how his mother’s lung cancer changed everything (8:15), why the stoners won’t make it (12:45), carving out a beachhead (15:15), building credibility for weed (18:40), the plant’s legal status in Britain (22:30), its potential as a cancer treatment (23:00), what a cannabinoid is (25:50), getting Snoop Dogg as an investor (28:15), developing drugs (29:50), and a consumer brand (32:30), Mr Nice (33:45), Oprah’s cannabis venture (36:15), sourcing the plant (38:50), and waiting for the laws to catch up (39:45). Hosted on Acast. See acast.com/privacy for more information.

The Sunday Times’ tech correspondent Danny Fortson brings on Neil Mahapatra, founder of Kingsley Capital and Oxford Cannabinoid Technologies, to talk about his early days in investment banking (3:30), getting a job with Lord Rothschild (5:50), setting up his own investment firm (7:30), how his mother’s lung cancer changed everything (8:15), why the stoners won’t make it (12:45), carving out a beachhead (15:15), building credibility for weed (18:40), the plant’s legal status in Britain (22:30), its potential as a cancer treatment (23:00), what a cannabinoid is (25:50), getting Snoop Dogg as an investor (28:15), developing drugs (29:50), and a consumer brand (32:30), Mr Nice (33:45), Oprah’s cannabis venture (36:15), sourcing the plant (38:50), and waiting for the laws to catch up (39:45). Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for more information.

Mr Nice's Neil Mahapatra: "Every mammal can get high"